search
Back to results

A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability (DIVA)

Primary Purpose

Hypotension

Status
Completed
Phase
Phase 2
Locations
Singapore
Study Type
Interventional
Intervention
vasopressor delivery automated system
phenylephrine
ephedrine
manual vasopressor delivery
Sponsored by
KK Women's and Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypotension focused on measuring Hypotension

Eligibility Criteria

21 Years - 45 Years (Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • age 21-45 years old,
  • weight 40-90 kg,
  • height 145-170 cm

Exclusion Criteria:

  • contraindications to spinal anaesthesia,
  • allergy to drugs used in the study, and
  • those with uncontrolled medical conditions such as hypertension, diabetes mellitus, and cardiovascular disease

Sites / Locations

  • KK Women's and Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

vasopressor delivery automated system

manual vasopressor delivery

Arm Description

vasopressor delivery automated system administering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique

manual bolus delivering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique

Outcomes

Primary Outcome Measures

Hypotension
Systolic blood pressure less than 80% of baseline systolic blood pressure

Secondary Outcome Measures

Hypertension
Systolic blood pressure more than 120% of baseline systolic blood pressure
Nausea and vomiting
Nausea and vomiting during Caesarean section

Full Information

First Posted
October 26, 2014
Last Updated
March 7, 2018
Sponsor
KK Women's and Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02277730
Brief Title
A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability
Acronym
DIVA
Official Title
A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability to Improve Perioperative Outcome During Spinal Anaesthesia for Caesarean Section
Study Type
Interventional

2. Study Status

Record Verification Date
August 2017
Overall Recruitment Status
Completed
Study Start Date
May 2013 (Actual)
Primary Completion Date
November 2017 (Actual)
Study Completion Date
December 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
KK Women's and Children's Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Hypotension occurs commonly during spinal anaesthesia for caesarean section with maternal and fetal adverse effects. The investigators developed a double-vasopressor automated system incorporating continuous non-invasive haemodynamic monitoring using NexfinTM with a two-step algorithm.
Detailed Description
Hypotension occurs commonly during spinal anaesthesia for caesarean section with maternal and fetal adverse effects. We developed a double-vasopressor automated system incorporating continuous non-invasive haemodynamic monitoring using Nexfin cardiac output monitor with a two-step algorithm. The system delivered phenylephrine 25 mcg or ephedrine 2 mg (if heart rate<60 beats.min-1) every 30 seconds when systolic blood pressure was between 90-100% of baseline. The system delivered phenylephrine 50 mcg or ephedrine 4 mg (if heart rate<60 beats.min-1) every 30 seconds when systolic blood pressure was <90% of baseline. A randomised controlled trial will be done to compare with manual bolus technique. With the manual bolus technique, phenylephrine 50mcg or ephedrine 4mg (if heart rate<60 beats.min-1) every 60 seconds when systolic blood pressure was between 90-100% of baseline. The system delivered phenylephrine 100mcg or ephedrine 8mg (if heart rate<60 beats.min-1) every 60 seconds when systolic blood pressure was <90% of baseline.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypotension
Keywords
Hypotension

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
252 (Actual)

8. Arms, Groups, and Interventions

Arm Title
vasopressor delivery automated system
Arm Type
Experimental
Arm Description
vasopressor delivery automated system administering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique
Arm Title
manual vasopressor delivery
Arm Type
Active Comparator
Arm Description
manual bolus delivering phenylephrine and ephedrine using a 2 step algorithm vasopressor delivery technique
Intervention Type
Device
Intervention Name(s)
vasopressor delivery automated system
Other Intervention Name(s)
vasopressor delivery technique
Intervention Description
vasopressor delivery using phenylephrine and ephedrine
Intervention Type
Drug
Intervention Name(s)
phenylephrine
Other Intervention Name(s)
vasopressor
Intervention Type
Drug
Intervention Name(s)
ephedrine
Other Intervention Name(s)
vasopressor
Intervention Type
Device
Intervention Name(s)
manual vasopressor delivery
Primary Outcome Measure Information:
Title
Hypotension
Description
Systolic blood pressure less than 80% of baseline systolic blood pressure
Time Frame
1 day
Secondary Outcome Measure Information:
Title
Hypertension
Description
Systolic blood pressure more than 120% of baseline systolic blood pressure
Time Frame
1 day
Title
Nausea and vomiting
Description
Nausea and vomiting during Caesarean section
Time Frame
1 day

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age 21-45 years old, weight 40-90 kg, height 145-170 cm Exclusion Criteria: contraindications to spinal anaesthesia, allergy to drugs used in the study, and those with uncontrolled medical conditions such as hypertension, diabetes mellitus, and cardiovascular disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ban L Sng, FANZCA
Organizational Affiliation
KK Women's and Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
KK Women's and Children's Hospital
City
Singapore
ZIP/Postal Code
229899
Country
Singapore

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
34101716
Citation
Du EW, Tan HS, Tan CW, Sultana R, Sng BL. Heart rate variability and haemodynamic factors associated with hypotension during spinal anaesthesia for caesarean delivery: A case-control study. Eur J Anaesthesiol. 2022 Mar 1;39(3):219-226. doi: 10.1097/EJA.0000000000001551.
Results Reference
derived
PubMed Identifier
29373334
Citation
Sng BL, Du W, Lee MX, Ithnin F, Mathur D, Leong WL, Sultana R, Han NR, Sia ATH. Comparison of double intravenous vasopressor automated system using nexfin versus manual vasopressor bolus administration for maintenance of haemodynamic stability during spinal anaesthesia for caesarean delivery: A randomised double-blind controlled trial. Eur J Anaesthesiol. 2018 May;35(5):390-397. doi: 10.1097/EJA.0000000000000779.
Results Reference
derived

Learn more about this trial

A Novel Closed-loop Integrated System for the Maintenance of Haemodynamic Stability

We'll reach out to this number within 24 hrs